Vis enkel innførsel

dc.contributor.authorMundal, Liv
dc.contributor.authorHovland, Anders
dc.contributor.authorIgland, Jannicke
dc.contributor.authorVeierød, Marit Bragelien
dc.contributor.authorHolven, Kirsten Bjørklund
dc.contributor.authorBogsrud, Martin Prøven
dc.contributor.authorTell, Grethe S.
dc.contributor.authorLeren, Trond Paul
dc.contributor.authorRetterstøl, Kjetil
dc.coverage.spatialNorwayen_US
dc.date.accessioned2020-02-24T14:08:31Z
dc.date.available2020-02-24T14:08:31Z
dc.date.created2019-11-11T13:59:20Z
dc.date.issued2019
dc.identifier.citationMundal, L. J., Hovland, A., Igland, J., Veierød, M. B., Holven, K. B., Bogsrud, M. P., . . . Retterstøl, K. (2019). Association of low-density lipoprotein cholesterol with risk of aortic valve stenosis in familial hypercholesterolemia. JAMA Cardiology, 4(11).en_US
dc.identifier.issn2380-6583
dc.identifier.urihttps://hdl.handle.net/11250/2643495
dc.descriptionAuthors' accepted manuscript (postprint). Available 2020-10-16.en_US
dc.description.abstractImportance Aortic valve stenosis (AS) is the most common valve disease. Elevated levels of low-density lipoprotein (LDL) cholesterol are a risk factor; however, lipid-lowering treatment seems not to prevent progression of AS. The importance of LDL cholesterol in the development of AS thus remains unclear. People with familial hypercholesterolemia (FH) have elevated LDL cholesterol levels from birth and until lipid-lowering treatment starts. Thus, FH may serve as a model disease to study the importance of LDL cholesterol for the development of AS. Objective To compare the incidence of AS per year in all genetically proven patients with FH in Norway with the incidence of these diseases in the total Norwegian population of about 5 million people. Design, Setting, and Participants This is a registry-based prospective cohort study of all Norwegian patients with FH with regard to first-time AS between 2001 and 2009. All genotyped patients with FH in Norway were compared with the total Norwegian populations through linkage with the Cardiovascular Disease in Norway project and the Norwegian Cause of Death Registry regarding occurrence of first-time AS. Data were analyzed between January 1, 2018, and December 31, 2018. Main Outcomes and Measures Standardized incidence ratios. Results In total, 53 cases of AS occurred among 3161 persons (1473 men [46.6%]) with FH during 18 300 person-years of follow-up. Mean age at inclusion and at time of AS were 39.9 years (range, 8-91 years) and 65 years (range, 44-88 years), respectively. Total standardized incidence ratios were 7.9 (95% CI, 6.1-10.4) for men and women combined, 8.5 (95% CI, 5.8-12.4) in women, and 7.4 (95% CI, 5.0-10.9) in men, respectively, indicating marked increased risk of AS compared with the general Norwegian population. Conclusions and Relevance In this prospective registry study, we demonstrate a marked increase in risk of AS in persons with FH.en_US
dc.language.isoengen_US
dc.publisherAmerican Medical Associationen_US
dc.titleAssociation of low-density lipoprotein cholesterol with risk of aortic valve stenosis in familial hypercholesterolemiaen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionacceptedVersionen_US
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771en_US
dc.source.pagenumber1-5en_US
dc.source.journalJAMA cardiologyen_US
dc.identifier.doi10.1001/jamacardio.2019.3903
dc.identifier.cristin1746083
cristin.unitcode203,11,12,0
cristin.unitnameSenter for kunnskapsbasert praksis
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel